no spam, unsubscribe anytime.
A research initiative at Mayo will help doctors prescribe more effective chemotherapy for breast cancer patients based on their individual genomes and the genomes of their tumors.
"What is so exciting about this study is that it has the potential to really bring individualized medicine to our patients," said Matthew P. Goetz, M.D., Mayo Clinic Cancer Center oncologist and study co-leader. "It will transform how we conduct breast cancer research and how drug therapies are delivered to women with breast cancer."
The Breast Cancer Genome Guided Therapy Study (BEAUTY Project) looks at three whole-genome sequences: one from a patient's healthy cells before treatment and two tumor genomes — one before chemotherapy and one after.
Goetz was the the recipient of The Breast Cancer Site 2008 Research Scholar Award. GreaterGood.org donations to Mayo are made possible by contributions from The Breast Cancer Site's Gifts That Give More [tm] program.